PURE Bioscience, Inc. Notes Payable
PURE Bioscience, Inc. (PURE) had Notes Payable of $6.50 million as of 2026-04-30, per its 10-Q filed 2026-06-15.
Financial Statements › Balance Sheet › Liabilities › Notes Payable
us-gaap:NotesPayable · last filed 2026-06-15
- 2026-04-30: Notes Payable $6.50M.
- 2026-01-31: Notes Payable $6.14M.
- 2025-10-31: Notes Payable $5.68M.
- 2025-07-31: Notes Payable $5.24M.
| Period end | Notes Payable |
|---|---|
| 2026-04-30 | $6.50M 10-Q · filed 2026-06-15 |
| 2026-01-31 | $6.14M 10-Q · filed 2026-03-17 |
| 2025-10-31 | $5.68M 10-Q · filed 2025-12-15 |
| 2025-07-31 | $5.24M 10-K · filed 2025-10-29 |
| 2025-04-30 | $4.90M 10-Q · filed 2025-06-16 |
| 2025-01-31 | $3.98M 10-Q · filed 2025-03-17 |
| 2024-10-31 | $3.51M 10-Q · filed 2024-12-16 |
| 2024-07-31 | $2.95M 10-K · filed 2025-10-29 |
| 2024-04-30 | $2.40M 10-Q · filed 2024-06-14 |
| 2024-01-31 | $1.86M 10-Q · filed 2024-03-18 |
| 2023-10-31 | $1.83M 10-Q · filed 2023-12-14 |